This elevated cyclic AMP activates protein kinase A (PKA) and Epac2 pathways to potentiate glucose-dependent insulin secretion and insulin exocytosis, respectively [6]
What to watch for: Darkening of existing moles nearly universal with continued use Increased mole count new melanocytic nevi can appear Asymmetry or border changes these require immediate dermatological evaluation Darkening of areolas, genitals, and lips areas with high melanocyte density A systematic review of MT-2 case reports found that mole changes were among the most frequently reported dermatological effects, with four case reports describing melanomas emerging during or shortly after MT-2 use (Brennan et al., 2017)
When side effects are minimized, patients are better able to maintain adequate nutrition, hydration, and energy levels, all of which support consistency over time
Compounding and Manufacturing Risk Compounded GLP-1 medications introduce a separate layer of variability that is independent of dose size
These regions are part of the limbic-hypothalamic circuit (141)
